Back to VRCA
CITADEL ADVISORS LLC VRCA Position History
Verrica Pharmaceuticals Inc. • Healthcare
Quarters held
25
Latest value
$187K
Q3 2026
Peak value
$285K
First seen
Q1 2023
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2023 | $265K |
| Q1 2023 | $44K |
| Q1 2023 | $153K |
| Q1 2023 | $74K |
| Q2 2023 | $83K |
| Q2 2023 | $31K |
| Q2 2023 | $224K |
| Q2 2023 | $285K |
| Q3 2023 | $5K |
| Q3 2023 | $39K |
| Q3 2023 | $68K |
| Q4 2023 | $113K |
| Q4 2023 | $25K |
| Q2 2024 | $44K |
| Q2 2024 | $46K |
| Q2 2024 | $87K |
| Q2 2024 | $79K |
| Q3 2024 | $14K |
| Q3 2024 | $9K |
| Q4 2024 | $2K |
| Q4 2024 | $4K |
| Q4 2024 | $14K |
| Q2 2025 | $36K |
| Q3 2026 | $5 |
| Q3 2026 | $187K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $187K | 39.0K | — | — |
| Q3 2026 | $5 | 1 | — | — |
| Q2 2025 | $36K | 68.7K | — | — |
| Q4 2024 | $14K | 20.3K | — | — |
| Q4 2024 | $4K | 5.1K | — | — |
| Q4 2024 | $2K | 2.3K | — | — |
| Q3 2024 | $9K | 6.5K | — | — |
| Q3 2024 | $14K | 9.9K | — | — |
| Q2 2024 | $79K | 10.8K | — | — |
| Q2 2024 | $87K | 12.0K | — | — |
| Q2 2024 | $46K | 6.3K | — | — |
| Q2 2024 | $44K | 6.1K | — | — |
| Q4 2023 | $25K | 3.4K | — | — |
| Q4 2023 | $113K | 15.4K | — | — |
| Q3 2023 | $68K | 17.6K | — | — |
| Q3 2023 | $39K | 10.1K | — | — |
| Q3 2023 | $5K | 1.2K | — | — |
| Q2 2023 | $285K | 49.4K | — | — |
| Q2 2023 | $224K | 38.9K | — | — |
| Q2 2023 | $31K | 5.4K | — | — |
| Q2 2023 | $83K | 14.4K | — | — |
| Q1 2023 | $74K | 11.4K | — | — |
| Q1 2023 | $153K | 23.5K | — | — |
| Q1 2023 | $44K | 6.8K | — | — |
| Q1 2023 | $265K | 40.8K | — | — |
Other funds holding VRCA
$11M
$8.9M
$8.8M
$8.1M
$7.7M
$6.7M